H-Val-OBzl·Tos CAS:16652-76-9
Hauv kev tsim cov peptide, H-Val-OBzl·Tos ua haujlwm ua ib qho tseem ceeb tiv thaiv amino acid derivative uas dhau los ntawm kev tiv thaiv thiab kev ua haujlwm rau kev sib txuas nrog lwm cov amino acids los tsim cov saw peptide. Cov tshuaj no yog siv los tsim cov kab ke peptide tshwj xeeb uas qhia txog kev ua haujlwm ntawm lub cev lossis kev kho mob. Qhov huv si thiab kev ruaj khov ntawm H-Val-OBzl·Tos yog qhov tseem ceeb rau kev ua kom muaj txiaj ntsig zoo hauv kev tsim peptide, pab txhawb rau kev tsim cov tshuaj tshiab thiab cov tshuaj bioactive. Ntxiv mus, nws qhov kev sib raug zoo nrog cov txheej txheem solid-phase synthesis ua rau muaj kev koom ua ke zoo rau hauv cov peptide synthesizers, ua kom yooj yim rau kev tsim cov peptides thiab peptide tsev qiv ntawv rau kev tshawb nrhiav tshuaj thiab kev tshawb fawb. H-Val-OBzl·Tos ua lub luag haujlwm tseem ceeb hauv kev tsim cov qauv peptide sib txawv, ua rau nws muaj txiaj ntsig zoo rau kev daws teeb meem biomedical ntau yam thiab tshawb nrhiav txoj hauv kev tshiab rau kev kho mob. Zuag qhia tag nrho, H-Val-OBzl·Tos qhov tseem ceeb hauv kev tsim cov peptide nthuav dav thoob plaws kev tshawb fawb txog tshuaj, biotechnology, thiab tshuaj lom neeg, qhov twg nws txuas ntxiv pab txhawb kev tsim cov tshuaj kho mob tshiab thiab biopharmaceuticals, tsav kev nce qib hauv kev kho mob thiab kev tshawb fawb txog lub neej.
| Kev sau ua ke | C19H25NO5S |
| Kev Ntsuas | 99% |
| Qhov tsos | hmoov dawb |
| CAS Nr. | 16652-76-9 |
| Ntim khoom | Me me thiab ntau |
| Lub Neej Txee | 2 xyoos |
| Kev Khaws Cia | Khaws cia rau qhov chaw txias thiab qhuav |
| Daim Ntawv Pov Thawj | ISO. |








